GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:GXI - DE000A0LD6E6 - Common Stock
27.04 EUR
+0.5 (+1.88%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 19 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
GXI had a positive operating cash flow in the past year.
In the past 5 years GXI has always been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
GXI's Return On Assets of 0.50% is on the low side compared to the rest of the industry. GXI is outperformed by 89.47% of its industry peers.
With a Return On Equity value of 1.67%, GXI is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
GXI has a Return On Invested Capital of 2.79%. This is amonst the worse of the industry: GXI underperforms 89.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GXI is below the industry average of 9.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
With a Profit Margin value of 1.04%, GXI is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
GXI has a Operating Margin of 5.99%. This is amonst the worse of the industry: GXI underperforms 89.47% of its industry peers.
GXI's Operating Margin has improved in the last couple of years.
GXI has a Gross Margin of 26.89%. This is in the lower half of the industry: GXI underperforms 78.95% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
GXI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GXI has a worse debt to assets ratio.
2.2 Solvency
GXI has an Altman-Z score of 0.96. This is a bad value and indicates that GXI is not financially healthy and even has some risk of bankruptcy.
GXI has a worse Altman-Z score (0.96) than 78.95% of its industry peers.
GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
GXI has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: GXI underperforms 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.96 |
ROIC/WACC0.35
WACC8.05%
2.3 Liquidity
A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
With a Current ratio value of 0.98, GXI is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
GXI has a Quick Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.52, GXI is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
GXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
Based on estimates for the next years, GXI will show a small growth in Earnings Per Share. The EPS will grow by 6.02% on average per year.
The Revenue is expected to grow by 7.40% on average over the next years.
EPS Next Y-33.1%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
EPS Next 5Y6.02%
Revenue Next Year13.41%
Revenue Next 2Y8.75%
Revenue Next 3Y7.82%
Revenue Next 5Y7.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.33, the valuation of GXI can be described as very cheap.
Based on the Price/Earnings ratio, GXI is valued cheaper than 100.00% of the companies in the same industry.
GXI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
The Price/Forward Earnings ratio is 7.77, which indicates a rather cheap valuation of GXI.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
GXI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.56, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.33 | ||
| Fwd PE | 7.77 |
4.2 Price Multiples
94.74% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.42 |
4.3 Compensation for Growth
GXI's earnings are expected to decrease with -2.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
5. Dividend
5.1 Amount
With a yearly dividend of 0.16%, GXI is not a good candidate for dividend investing.
The stock price of GXI dropped by -38.45% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
GXI's Dividend Yield is slightly below the industry average, which is at 0.70.
With a Dividend Yield of 0.16, GXI pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
GXI pays out 10.12% of its income as dividend. This is a sustainable payout ratio.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
FRA:GXI (12/1/2025, 11:43:07 AM)
27.04
+0.5 (+1.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.48%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap933.96M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts65.22
Price Target38.74 (43.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-37.64%
PT rev (3m)-41.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)-18.09%
EPS NY rev (3m)-18.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-3.1%
Revenue NY rev (3m)-3.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.33 | ||
| Fwd PE | 7.77 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | 3.68 | ||
| P/B | 0.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.42 |
EPS(TTM)3.69
EY13.65%
EPS(NY)3.48
Fwd EY12.87%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY27.15%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.96 |
F-Score4
WACC8.05%
ROIC/WACC0.35
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-33.1%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
EPS Next 5Y6.02%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.41%
Revenue Next 2Y8.75%
Revenue Next 3Y7.82%
Revenue Next 5Y7.4%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year113.62%
EBIT Next 3Y38.46%
EBIT Next 5Y21.19%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -33.1% in the next year.